Telomir Pharmaceuticals, Inc. Common Stock (TELO) Stock Analysis

Telomir Pharmaceuticals, Inc. Common Stock (TELO) is a publicly traded company in the HEALTHCARE sector. It trades at $1.24, carries a market capitalization of $85.97M. This page summarizes the public market data, fundamentals, and frequently asked questions for TELO, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Telomir Pharmaceuticals, Inc. Common Stock currently has a Neutral sentiment score of -0.00.

About Telomir Pharmaceuticals, Inc. Common Stock

Telomir Pharmaceuticals, Inc. (Ticker: TELO) is a pre-clinical-stage biopharmaceutical company based in Baltimore, Maryland, dedicated to advancing innovative therapeutic solutions targeting human stem cell disorders. The company is focused on harnessing proprietary technologies to develop novel treatments that have the potential to improve health outcomes in regenerative medicine. With a strong emphasis on research and development, Telomir aims to position itself at the forefront of stem cel...

GNG Research Analysis

GNG Research scores Telomir Pharmaceuticals, Inc. Common Stock (TELO) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TELO.

Frequently Asked Questions

Does TELO pay dividends?

Telomir Pharmaceuticals, Inc. Common Stock (TELO) does not currently pay a regular dividend.

What is TELO's market cap?

Telomir Pharmaceuticals, Inc. Common Stock (TELO) has a market capitalization of $85.97M with a current stock price of $1.24.